1vcb

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1vcb" size="450" color="white" frame="true" align="right" spinBox="true" caption="1vcb, resolution 2.7&Aring;" /> '''THE VHL-ELONGINC-ELO...)
Next diff →

Revision as of 17:36, 12 November 2007


1vcb, resolution 2.7Å

Drag the structure with the mouse to rotate

THE VHL-ELONGINC-ELONGINB STRUCTURE

Contents

Overview

Mutation of the VHL tumor suppressor is associated with the inherited von, Hippel-Lindau (VHL) cancer syndrome and the majority of kidney cancers., VHL binds the ElonginC-ElonginB complex and regulates levels of, hypoxia-inducible proteins. The structure of the ternary complex at 2.7, angstrom resolution shows two interfaces, one between VHL and ElonginC and, another between ElonginC and ElonginB. Tumorigenic mutations frequently, occur in a 35-residue domain of VHL responsible for ElonginC binding. A, mutational patch on a separate domain of VHL indicates a second, macromolecular binding site. The structure extends the similarities to the, SCF (Skp1-Cul1-F-box protein) complex that targets proteins for, degradation, supporting the hypothesis that VHL may function in an, analogous pathway.

Disease

Known diseases associated with this structure: Hemangioblastoma, cerebellar, somatic OMIM:[608537], Pheochromocytoma OMIM:[608537], Polycythemia, benign familial OMIM:[608537], Renal cell carcinoma, somatic OMIM:[608537], von Hippel-Lindau syndrome OMIM:[608537]

About this Structure

1VCB is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function., Stebbins CE, Kaelin WG Jr, Pavletich NP, Science. 1999 Apr 16;284(5413):455-61. PMID:10205047

Page seeded by OCA on Mon Nov 12 19:43:09 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools